StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio operating margin

Operating margin is operating income as a percentage of revenue.

Mustang Bio's operating margin for the twelve months ending Sep 30, 2018 was -70206.0%.

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2018Mar 31, 2018-12954.0%–

More Mustang Bio figures

See a number that looks wrong?